← Oncology Approval Tracker

FDA DECISION ·

Keytruda

pembrolizumab · Merck Sharp & Dohme

FDA approvalNew or expanded indicationCutaneous squamous cell carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Patients with recurrent or metastatic cutaneous squamous cell carcinoma that could not be cured with surgery or radiation.

LAMPGEN ANALYSIS

Why it matters

Added systemic immunotherapy when local curative treatment was unavailable.

What research teams should watch

Document multidisciplinary assessment of surgery and radiotherapy and standardize imaging or lesion photography.

PRIMARY RECORDS

Sources